Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes

Clinical trial NCT07770737 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07770737
Sponsor: Dongtan Sacred Heart Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus (T2DM)Cardiovascular Diseases Stage B Heart Failure

Start date: 2026-09-01
Primary completion: 2027-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.